ESC 365 - Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry

ESC Premium Access

Use of statins and adverse outcomes in patients with atrial fibrillation: the EURObservational research programme atrial fibrillation (EORP-AF) general pilot registry

Session: New insights in statin therapy

Topic: Drug therapy

Speaker: Associate Professor M. Proietti (Milan, IT)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)

11 presentations

1 follower

4 more presentations in this session

State of the Art: statin therapy

Speaker: Professor T. Pedersen (Oslo, NO)

Efficacy and safety of alternate-day versus daily dosing of statins: A systematic review and meta-analysis

Speaker: Professor M. Banach (Lodz, PL)

Comparison the effect on fasting blood sugar between atorvastatin, rousuvastatin and pitavastatin in Korean population

Speaker: Assistant Professor C. Kim (Daegu, KR)

Towards a broader understanding of statins

Speaker: Professor H. Drexel (Feldkirch, AT)

Access the full session

New insights in statin therapy

Speakers: Associate Professor M. Proietti, Professor T. Pedersen, Professor M. Banach, Assistant Professor C. Kim, Professor H. Drexel

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources